Éric Deconinck

11.7k total citations
221 papers, 4.9k citations indexed

About

Éric Deconinck is a scholar working on Hematology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Éric Deconinck has authored 221 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 95 papers in Hematology, 67 papers in Oncology and 54 papers in Pathology and Forensic Medicine. Recurrent topics in Éric Deconinck's work include Hematopoietic Stem Cell Transplantation (63 papers), Acute Myeloid Leukemia Research (53 papers) and Lymphoma Diagnosis and Treatment (49 papers). Éric Deconinck is often cited by papers focused on Hematopoietic Stem Cell Transplantation (63 papers), Acute Myeloid Leukemia Research (53 papers) and Lymphoma Diagnosis and Treatment (49 papers). Éric Deconinck collaborates with scholars based in France, Italy and United States. Éric Deconinck's co-authors include Nöel Milpied, Vincent Delwail, Jean‐Yves Cahn, Rémy Gressin, Mohamad Mohty, Philippe Colombat, Jean‐Luc Harousseau, Samuel Limat, Yvan Vander Heyden and Christophe Ferrand and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Éric Deconinck

206 papers receiving 4.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Éric Deconinck France	40	1.8k	1.7k	1.6k	1.0k	702	221	4.9k
Marc Maynadié France	36	1.4k 0.8×	1.7k 1.0×	1.8k 1.1×	1.2k 1.2×	747 1.1×	132	5.5k
Thomas C. Shea United States	38	1.8k 1.0×	2.5k 1.4×	1.1k 0.7×	618 0.6×	1.6k 2.3×	172	5.6k
David D. Hurd United States	35	2.4k 1.3×	1.6k 0.9×	990 0.6×	808 0.8×	1.2k 1.7×	159	4.8k
Karen H. Antman United States	48	1.2k 0.7×	3.5k 2.0×	1.3k 0.8×	593 0.6×	1.2k 1.7×	146	8.4k
Jon P. Gockerman United States	36	1.1k 0.6×	1.5k 0.9×	879 0.5×	908 0.9×	836 1.2×	128	4.4k
Kenneth R. Carson United States	32	724 0.4×	1.9k 1.1×	904 0.6×	437 0.4×	565 0.8×	150	4.2k
Andrew M. Evens United States	49	973 0.5×	3.5k 2.0×	3.3k 2.0×	1.2k 1.1×	1.3k 1.8×	305	7.8k
Vincent Lévy France	42	829 0.5×	1.3k 0.7×	1.3k 0.8×	1.4k 1.4×	568 0.8×	189	5.3k
Daniel R. Couriel United States	45	4.7k 2.7×	1.8k 1.0×	644 0.4×	895 0.9×	795 1.1×	155	6.6k
Sameer Bakhshi India	34	685 0.4×	1.4k 0.8×	677 0.4×	399 0.4×	911 1.3×	509	5.2k

Countries citing papers authored by Éric Deconinck

Since Specialization

Citations

This map shows the geographic impact of Éric Deconinck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Éric Deconinck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Éric Deconinck more than expected).

Fields of papers citing papers by Éric Deconinck

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Éric Deconinck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Éric Deconinck. The network helps show where Éric Deconinck may publish in the future.

Co-authorship network of co-authors of Éric Deconinck

This figure shows the co-authorship network connecting the top 25 collaborators of Éric Deconinck. A scholar is included among the top collaborators of Éric Deconinck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Éric Deconinck. Éric Deconinck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dachy, Guillaume, Myriam Labopin, Gèrard Socié, et al.. (2025). Impact of fludarabine dose on outcome after allo-HSCT with reduced intensity conditioning for older patients with AML. Bone Marrow Transplantation. 60(9). 1258–1264.

Angelucci, Emanuele, et al.. (2025). Real-world study of tagraxofusp monotherapy in relapsed or refractory blastic plasmacytoid dendritic cell neoplasm. Leukemia & lymphoma. 66(13). 2489–2497.

Subklewe, Marion, Nicolas Boissel, Stephan Mielke, et al.. (2024). Resolve AML 001: An Adaptive Open-Label Multicentre Phase 1/2 Trial, to Determine the Recommended Phase 2 Dose of Cctx-001, and to Assess Safety, Tolerability, and Clinical Activity in Patients with r/r AML. Blood. 144(Supplement 1). 2883.2–2883.2. 1 indexed citations

Pagès, Arnaud, Rudy Birsen, Adrien Contejean, et al.. (2024). Venetoclax–proteasome inhibitor–dexamethasone for unfit patients with blastic plasmacytoid dendritic cell neoplasm. Blood Advances. 9(4). 793–796. 2 indexed citations

Herling, Marco, et al.. (2024). Real world (RW) study of patients (pts) with relapsed or refractory (RR) blastic plasmacytoid dendritic cell neoplasm (BPDCN) treated with tagraxofusp (TAG).. Journal of Clinical Oncology. 42(16_suppl). e18533–e18533. 1 indexed citations

Arrieta‐Bolaños, Esteban, Tobias Gedde‐Dahl, Marie Robin, et al.. (2024). Directionality of HLA-DP permissive mismatches improves risk prediction in HCT for acute leukemia and MDS. Blood. 144(16). 1747–1751. 4 indexed citations

Pasquier, Florence, Christophe Marzac, Éric Deconinck, et al.. (2022). An inherited gain‐of‐function risk allele in EPOR predisposes to familial JAK2^V617F myeloproliferative neoplasms. British Journal of Haematology. 198(1). 131–136. 7 indexed citations

Fatobene, Giancarlo, Fernanda Volt, Frederico Rafael Moreira, et al.. (2020). Optimizing selection of double cord blood units for transplantation of adult patients with malignant diseases. Blood Advances. 4(24). 6327–6335. 7 indexed citations

Favier, Rémi, Xavier Roussel, Sylvain Audia, et al.. (2019). Correction of Severe Myelofibrosis, Impaired Platelet Functions and Abnormalities in a Patient with Gray Platelet Syndrome Successfully Treated by Stem Cell Transplantation. Platelets. 31(4). 536–540. 9 indexed citations

10.

Warda, Walid, Fabrice Larosa, Éric Deconinck, et al.. (2018). CML Hematopoietic Stem Cells Expressing IL1RAP Can Be Targeted by Chimeric Antigen Receptor–Engineered T Cells. Cancer Research. 79(3). 663–675. 68 indexed citations

11.

Poiré, Xavier, Myriam Labopin, Emmanuelle Polge, et al.. (2018). Hematopoietic stem cell transplantation for adult patients with isolated NPM1 mutated acute myeloid leukemia in first remission. American Journal of Hematology. 94(2). 231–239. 13 indexed citations

12.

Chauchet, Adrien, Frédéric Grenouillet, Jenny Knapp, et al.. (2013). 923 EMERGENCE OF A NEW OPPORTUNISTIC INFECTION IN EUROPE: HEPATIC ALVEOLAR ECHINOCOCCOSIS. A FIFTY-CASE REPORT. Journal of Hepatology. 58. S381–S381. 4 indexed citations

13.

Solal‐Céligny, Philippe, Monica Bellei, Luigi Marcheselli, et al.. (2012). Watchful Waiting in Low–Tumor Burden Follicular Lymphoma in the Rituximab Era: Results of an F2-Study Database. Journal of Clinical Oncology. 30(31). 3848–3853. 88 indexed citations

14.

Colombat, P, Nicole Brousse, Gilles Salles, et al.. (2012). Rituximab induction immunotherapy for first-line low-tumor-burden follicular lymphoma: survival analyses with 7-year follow-up. Annals of Oncology. 23(9). 2380–2385. 36 indexed citations

15.

Gressin, Rémy, Sylvie Caulet-Maugendre, Éric Deconinck, et al.. (2010). Evaluation of the (R)VAD+C regimen for the treatment of newly diagnosed mantle cell lymphoma. Combined results of two prospective phase II trials from the French GOELAMS group. Haematologica. 95(8). 1350–1357. 29 indexed citations

16.

Legrand, Faézeh, Frédéric Grenouillet, Fabrice Larosa, et al.. (2010). Diagnosis and treatment of digestive cryptosporidiosis in allogeneic haematopoietic stem cell transplant recipients: a prospective single centre study. Bone Marrow Transplantation. 46(6). 858–862. 29 indexed citations

17.

Fagnoni, Philippe, Nöel Milpied, Samuel Limat, et al.. (2009). Cost Effectiveness of High-Dose Chemotherapy with Autologous Stem Cell Support as Initial Treatment of Aggressive Non-Hodgkin's Lymphoma. HAL (Le Centre pour la Communication Scientifique Directe). 1 indexed citations

18.

Daguindau, Étienne, Bruno Lioure, Agnès Buzyn, et al.. (2009). Evidence for anti-tumour effect of allogeneic haematopoietic SCT in cases without sustained donor engraftment. Bone Marrow Transplantation. 45(1). 177–180. 4 indexed citations

19.

Perruche, Sylvain, R Angonin, Jean‐Yves Cahn, et al.. (2003). A Single Intravenous Infusion of Apoptotic Cells, An Alternative Cell-Based Therapy Approach Facilitating Hematopoietic Cell Engraftment, Did Not Induce Autoimmunity. Journal of Hematotherapy & Stem Cell Research. 12(4). 451–459. 11 indexed citations

20.

Deconinck, Éric, T. Lamy, C. Foussard, et al.. (2000). Autologous stem cell transplantation for anaplastic large‐cell lymphomas: results of a prospective trial. British Journal of Haematology. 109(4). 736–742. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact